Major Earnings & Financial Updates
Automotive, Tech & Retail Results
Zeekr Group (ZK) reported strong Q4 and full‐year 2024 unaudited financial results, with Q4 deliveries nearly doubling YoY and vehicle sales surging to over RMB19.3 billion. This robust performance highlights accelerated growth in the premium new energy vehicle segment.
111, Inc. (YI) surprised investors by posting its first-ever annual operating profit and positive operating cash flow for fiscal 2024, reversing a significant loss from 2023 while streamlining expenses.
VEON (VEON) delivered an upbeat FY24 and Q4 trading update, with revenue growing by 8.3% YoY and digital services contributing strong direct growth. The company also announced the commencement of a USD 35 million share buyback, underlining its confidence in current valuations.
PDD Holdings (PDD) reported impressive Q4 results, with total revenues up 24% YoY and a significant surge in key business segments that drove operating profit higher, reinforcing its dominant position in the e‐commerce space.
Accenture (ACN) posted solid Q2 FY25 figures with U.S. dollar revenues reaching USD 16.7 billion, new bookings amounting to USD 20.9 billion – including notable Generative AI orders – and improved margins, reflecting continued growth in its consulting and technology segments.
FactSet (FDS) reported Q2 FY25 results with GAAP revenues hitting USD 570.7 million and diluted EPS rising 3.0% to USD 3.76. Improved free cash flow and robust organic growth underscore its value proposition for institutional investors.
Rockwell Medical (RMTI) achieved record net sales of USD 101.5 million in 2024 – up 21% from the prior year – alongside a doubling of gross profit, even as it braces for revenue headwinds from a key customer transition early next year.
Baozun (BZUN) recorded Q4 net revenues of RMB2,994.4 million with double-digit growth in both its e‐commerce and brand management segments, bolstered by increased brand partner counts and strong cash reserves.
Commercial Metals Company (CMC) delivered Q2 FY25 results with adjusted earnings down YoY but maintained solid liquidity at USD 758.4 million and repurchased shares to support shareholder value.
Titan Machinery (TITN) reported Q4 FY25 results showing a significant inventory reduction of USD 304 million in Q4 and total FY2025 revenue of USD 2.7 billion, despite a challenging operating environment and a net loss of USD 36.9 million.
Designer Brands Inc. (DBI) returned to positive comparable sales growth in Q4 after nine quarters of decline, with net sales at USD 713.6 million and a modest 0.5% increase in comparable sales, reflecting renewed momentum in the apparel retail sector.
Caleres (CAL) achieved a key strategic turnaround in Q4 2024, with net revenues down slightly at USD 441.7 million but improved operating income margins and an 11.1% dividend increase, setting an optimistic 2025 outlook.
M&A and Strategic Transactions
In a blockbuster move, QXO (QXO) announced a definitive merger agreement to acquire Beacon Roofing Supply for approximately USD 11 billion, a deal unanimously approved by both boards.
Eyenovia (EYEN) entered into a non-binding LOI for a reverse merger with Betaliq, potentially reshaping the eye care market by combining EyeSol® technology and Optejet® platforms.
RYVYL (RVYL) secured major Payments-as-a-Service contracts projected to onboard nearly one million new accounts over the next 12 months, bolstering its revenue guidance for 2025.
T-Mobile (TMUS) is finalizing the sale of its 800 MHz spectrum portfolio to a leading private investment firm, a strategic transaction expected to enhance network infrastructure and unlock additional value.
Biotech & Clinical Developments
Sionna Therapeutics (SION) delivered positive Q4 and full-year 2024 results, driven by advancements in its cystic fibrosis treatment programs and promising interim data from its Phase 1 MAD cohorts.
BD (BDX) reached a clinical milestone in its ongoing Phase 1 trial for the GalaFLEX LITE™ Scaffold, which is designed to reduce the recurrence of capsular contracture in breast implant revision surgeries.
ICON (ICLR) became the first major clinical research organization to fully integrate Medidata Clinical Data Studio into its workflows – a move that enhances AI-driven data management and monitoring across its global studies.
Aurora Cannabis (ACB) announced a breakthrough discovery of a novel genetic resistance marker against powdery mildew, promising to reduce production costs and enhance product quality in a highly competitive market.
Immuneering (IMRX) appointed Dr. Igor Matushansky as Chief Medical Officer. Dr. Matushansky will lead clinical activities for IMM-1-104, building on encouraging Phase 2a results in multiple cancers.
Corporate & Strategic Partnerships
Aurora Mobile (JG) forged a strategic alliance between its GPTBots.ai platform and Southeast Asia’s ZANROO, aiming to accelerate AI-powered business solutions and drive regional digital transformation.
Plug Power (PLUG) reinforced its commitment to the hydrogen economy as its CEO announced that he will take 50% of his 2025 compensation in company stock, directly aligning executive interests with long-term shareholder value.
Other Sectoral Updates
Gold Royalty Corp. (GROY) posted record Q4 revenue of USD 3.4 million and full-year results showing record revenue and positive operating cash flow, forecasting significant growth over the next five years.
Simulations Plus (SLP) reported robust Q2 FY25 earnings with second-quarter revenues demonstrating a 23.3% increase in free cash flow and strong growth in biosimulation services that cater to the biopharma industry.
Aurora Cannabis (ACB) – beyond its breakthrough discovery – continues to innovate as it integrates its proprietary genetic resistance technology into its breeding programs to secure long-term competitive advantage.
